Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.

Li B, Cai Y, Qi C, Hansen R, Ding C, Mitchell TC, Yan J.

Clin Cancer Res. 2010 Nov 1;16(21):5153-64. doi: 10.1158/1078-0432.CCR-10-0820. Epub 2010 Sep 20.

2.

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

Qi C, Cai Y, Gunn L, Ding C, Li B, Kloecker G, Qian K, Vasilakos J, Saijo S, Iwakura Y, Yannelli JR, Yan J.

Blood. 2011 Jun 23;117(25):6825-36. doi: 10.1182/blood-2011-02-339812. Epub 2011 Apr 29.

3.

β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.

Tian J, Ma J, Ma K, Guo H, Baidoo SE, Zhang Y, Yan J, Lu L, Xu H, Wang S.

Eur J Immunol. 2013 May;43(5):1220-30. doi: 10.1002/eji.201242841. Epub 2013 Mar 25.

4.

Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.

Tian J, Ma J, Ma K, Ma B, Tang X, Baidoo SE, Tong J, Yan J, Lu L, Xu H, Wang S.

PLoS One. 2012;7(10):e46936. doi: 10.1371/journal.pone.0046936. Epub 2012 Oct 15.

5.

Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.

Masuda Y, Nawa D, Nakayama Y, Konishi M, Nanba H.

J Leukoc Biol. 2015 Dec;98(6):1015-25. doi: 10.1189/jlb.1A0814-415RR. Epub 2015 Aug 21.

PMID:
26297795
6.

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.

Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD.

J Immunol. 2004 Jul 15;173(2):797-806.

7.

The effects of β-glucans on dendritic cells and implications for cancer therapy.

Albeituni SH, Yan J.

Anticancer Agents Med Chem. 2013 Jun;13(5):689-98. Review.

PMID:
23092290
8.

β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.

Ning Y, Xu D, Zhang X, Bai Y, Ding J, Feng T, Wang S, Xu N, Qian K, Wang Y, Qi C.

Int J Cancer. 2016 Jun 1;138(11):2713-23. doi: 10.1002/ijc.30002. Epub 2016 Feb 8.

9.

Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.

Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H.

Int J Cancer. 2013 Jul;133(1):108-19. doi: 10.1002/ijc.27999. Epub 2013 Feb 15.

10.

Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

Hong F, Hansen RD, Yan J, Allendorf DJ, Baran JT, Ostroff GR, Ross GD.

Cancer Res. 2003 Dec 15;63(24):9023-31.

11.

Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley.

Akramiene D, Grazeliene G, Didziapetriene J, Kevelaitis E.

Medicina (Kaunas). 2009;45(6):480-5.

12.

Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.

Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F.

J Immunol. 2013 Aug 15;191(4):1984-92. doi: 10.4049/jimmunol.1301135. Epub 2013 Jul 15.

13.

Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.

Tian J, Ma J, Wang S, Yan J, Chen J, Tong J, Wu C, Liu Y, Ma B, Mao C, Jiao Z, Shao Q, Lu L, Xu H.

Cell Immunol. 2011;270(2):183-7. doi: 10.1016/j.cellimm.2011.05.003. Epub 2011 May 10.

PMID:
21636079
14.

Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.

Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE, Yan J.

J Immunol. 2006 Aug 1;177(3):1661-9.

15.
16.

Oral administration of a soluble 1-3, 1-6 beta-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice.

Harnack U, Eckert K, Fichtner I, Pecher G.

Int Immunopharmacol. 2009 Oct;9(11):1298-303. doi: 10.1016/j.intimp.2009.07.013. Epub 2009 Aug 4.

PMID:
19664725
17.

β-Glucan induces autophagy in dendritic cells and influences T-cell differentiation.

Ding J, Ning Y, Bai Y, Xu X, Sun X, Qi C.

Med Microbiol Immunol. 2019 Feb;208(1):39-48. doi: 10.1007/s00430-018-0556-z. Epub 2018 Aug 7.

PMID:
30088084
18.

Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.

Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM.

MBio. 2010 Jul 20;1(3). pii: e00164-10. doi: 10.1128/mBio.00164-10.

19.

Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.

Ohshio Y, Teramoto K, Hanaoka J, Tezuka N, Itoh Y, Asai T, Daigo Y, Ogasawara K.

Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16.

20.

Supplemental Content

Support Center